An interventional study of Shoulder mobilisation in Hemiplegia, sponsored by Centre Hospitalier Universitaire de la Réunion. Withdrawn. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2019-11-26.
Sponsored by Centre Hospitalier Universitaire de la Réunion · Not applicable, Interventional, and Supportive care
Hemiplegia is a high prevalence pathology with 1 per 1000 habitants in France. One of these complications is shoulder pain which affects about 35 to 70% of cases. The medical care of this complication is critical because it affects the patient's quality of life and also hinders participation in rehabilitation sessions slowing the recovery of independence in activities of daily living.
Literature confirmed the involvement of the scapula in the hemiplegic shoulder pain with his attitude pronounced lateral rotation. But no data to confirm that passive mobilization reduce shoulder pain.
Because no data available to permit us to determine the sample size we set-up this preliminary study to check if efficiency found in these preliminary data are consistent with an estimable real efficacy in a randomized trial feasible.
374 studies on the registry are indexed under Hemiplegia; 83 are open to participants now.
Browse Hemiplegia studies →Centre Hospitalier Universitaire de la Réunion is the lead sponsor of 137 studies on the registry; 35 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
The shoulder mobilisation is performed daily by a physiotherapist for 45 days.
Procedure: Shoulder mobilisation
early shoulder mobilisation
Pain evaluation with visual analogic scale
Proportion of patients reducing by at least 20 mm their score on the visual analogic scale (VAS) from baseline Day 45
Time frame: Change of pain evaluation between Day 0 and Day 45
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
This study is withdrawn, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre Hospitalier Universitaire de la Réunion